Cargando…
Analysis of immune status after iodine-125 permanent brachytherapy in prostate cancer
BACKGROUND: Permanent prostate brachytherapy (PPB) is an effective treatment choice for low and intermediate risk prostate cancer (PCa). However, the impact of PPB on tumor immune status is still poorly understood. This study aimed to assess the immune status in PCa patients before and at different...
Autores principales: | Du, E, Wang, Lin, Li, Chang-ying, Zhang, Chang-wen, Qu, Yan-chun, Liu, Ran-lu, Xu, Yong, Yang, Kuo, Zhang, Zhi-hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438076/ https://www.ncbi.nlm.nih.gov/pubmed/28546760 http://dx.doi.org/10.2147/OTT.S137491 |
Ejemplares similares
-
Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas
por: Wang, Congxiao, et al.
Publicado: (2020) -
Correction to: Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas
por: Wang, Congxiao, et al.
Publicado: (2020) -
Stereotactic iodine-125 brachytherapy for brain tumors: temporary versus permanent implantation
por: Ruge, Maximilian I, et al.
Publicado: (2012) -
An analysis of brachytherapy with computed tomography-guided permanent implantation of Iodine-125 seeds for recurrent nonkeratin nasopharyngeal carcinoma
por: Shen, Xinying, et al.
Publicado: (2015) -
Erectile function after permanent 125I prostate brachytherapy for localized prostate cancer
por: Njomnang Soh, Patrice, et al.
Publicado: (2013)